Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality Home
BiotechReality – Information Intelligence System for Biopharma
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#FDA #Eli Lilly and Company #Johnson&Johnson #Clinical Data #Quarterly Results #FDA Approval #Phase 3 Trials #Novo Nordisk

Tag: Rabies

Regulatory Approval Healthcare & Pharmaceuticals News Vaccines

Sanofi VaxRabeo Wins European Commission Approval as Next-Generation Rabies Vaccine for All Ages

  • By Regulatory Intelligence Desk
  • 19 November 2026
sanofi news

Sanofi VaxRabeo has won European Commission approval for rabies PrEP and PEP in all age groups. The Vero-cell vaccine has a 60-month shelf life and showed comparable antibody levels to Verorab and Imovax Rabies.

Tagged EMA, EMA Approval, EU, Rabies, Sanofi
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

LOTTE Biologics Songdo Plant 1 Lands First Major Commercial Manufacturing Agreement Ahead of Launch
CDMO Business Healthcare & Pharmaceuticals News

LOTTE Biologics Songdo Plant 1 Lands First Major Commercial Manufacturing Agreement Ahead of Launch

19 November 202619 November 2026
BiotechReality Business Intelligence Desk
Sanofi VaxRabeo Wins European Commission Approval as Next-Generation Rabies Vaccine for All Ages
Regulatory Approval Healthcare & Pharmaceuticals News Vaccines

Sanofi VaxRabeo Wins European Commission Approval as Next-Generation Rabies Vaccine for All Ages

19 November 202619 November 2026
Regulatory Intelligence Desk
Pfizer Starna Licensing Agreement: Pfizer Secures Exclusive In Vivo CAR-T Rights for Autoimmune Diseases in $330 Million Upfront Deal
Business Healthcare & Pharmaceuticals News

Pfizer Starna Licensing Agreement: Pfizer Secures Exclusive In Vivo CAR-T Rights for Autoimmune Diseases in $330 Million Upfront Deal

18 November 202618 November 2026
BiotechReality Business Intelligence Desk
Johnson & Johnson Announces $2.2 Billion Ollin Biosciences Acquisition to Add Phase 3 Eye Antibody OLN324
Business Clinical Trials Healthcare & Pharmaceuticals News

Johnson & Johnson Announces $2.2 Billion Ollin Biosciences Acquisition to Add Phase 3 Eye Antibody OLN324

17 November 202617 November 2026
BiotechReality Business Intelligence Desk
FDA Rejected Ivonescimab: Summit Therapeutics Receives Complete Response Letter for NSCLC BLA Based on HARMONi Study
Regulatory Healthcare & Pharmaceuticals News Oncology

FDA Rejected Ivonescimab: Summit Therapeutics Receives Complete Response Letter for NSCLC BLA Based on HARMONi Study

16 November 202616 November 2026
Clinical Trials & Data Desk
Novo Nordisk CagriSema REDEFINE 9 Trial Shows ~21% Average Weight Loss at Lower Doses at ObesityWeek 2026
Clinical Data Healthcare & Pharmaceuticals News

Novo Nordisk CagriSema REDEFINE 9 Trial Shows ~21% Average Weight Loss at Lower Doses at ObesityWeek 2026

15 November 202615 November 2026
Clinical Trials & Data Desk
Advertisement
BiotechReality JobFinder

  • Quality Systems Engineer – Boston Scientific, Dubai
    13 November 2026
  • Global Clinical Supply Business Support Coordinator – Pfizer, Makati
    9 November 2026
  • Senior Product Analyst – Novartis, India
    25 October 2026
  • Rare Disease Medical Science Liaison (MSL) – Amgen, Japan
    20 October 2026
  • Clinical Project Management Director – IQVIA
    16 October 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter